SCHEMBL38662990

SCHEMBL38662990

O=C(O)CN1Cc2ccccc2CC1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ SIRT1 Q96EB6 1/20 0.54
▸ ITGB3 P05106 1/20 0.47
▸ ITGA2B P08514 1/20 0.47
▸ ACHE P22303 1/20 0.46
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ ACE P12821 3/20 0.43
▸ MME P08473 1/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PER2 O15055 1/20 0.43
▸ CRY2 Q49AN0 1/20 0.43
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7931439 0.85 KDM4E (0.45) KDM4EALOX15TSHRSIRT1CYP2D6
SCHEMBL17244439 0.80 ITGB3 (0.51) KDM4EALOX15TSHRSIRT1ITGB3
SCHEMBL311850 0.79 KDM4E (0.71) KDM4EALOX15TSHRSIRT1KMT2A
SCHEMBL29676908 0.79 KDM4E (0.71) KDM4EALOX15TSHRSIRT1KMT2A
SCHEMBL7901979 0.77 ITGB3 (0.55) KDM4EALOX15TSHRSIRT1ITGB3
SCHEMBL8966163 0.77 ACHE (0.46) KDM4EALOX15TSHRSIRT1ACHE
SCHEMBL5191836 0.76 ITGB3 (0.52) KDM4EALOX15TSHRSIRT1ITGB3
SCHEMBL12545824 0.76 ITGB3 (0.48) KDM4EALOX15TSHRSIRT1ITGB3
Hydrochloric Acid SCHEMBL1371861 0.76 NOTUM (0.45) KDM4EALOX15KMT2AMAPTRAB9A
SCHEMBL23004832 0.75 ACHE (0.58) KDM4EALOX15TSHRSIRT1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101698-A1 HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF PROTAGONIST THERAPEUTICS, INC. (US) 2026-05-15 — — WO disclosed
Send feedback